- Home
- RFMZ vs SMTI Comparison
RFMZ vs SMTI Comparison
Compare RFMZ & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFMZ
- SMTI
- Stock Information
- Founded
- RFMZ 2021
- SMTI 1982
- Country
- RFMZ United States
- SMTI United States
- Employees
- RFMZ N/A
- SMTI N/A
- Industry
- RFMZ Trusts Except Educational Religious and Charitable
- SMTI Medical/Dental Instruments
- Sector
- RFMZ Finance
- SMTI Health Care
- Exchange
- RFMZ Nasdaq
- SMTI Nasdaq
- Market Cap
- RFMZ 310.0M
- SMTI 252.1M
- IPO Year
- RFMZ N/A
- SMTI N/A
- Fundamental
- Price
- RFMZ $12.65
- SMTI $27.95
- Analyst Decision
- RFMZ
- SMTI Strong Buy
- Analyst Count
- RFMZ 0
- SMTI 2
- Target Price
- RFMZ N/A
- SMTI $49.50
- AVG Volume (30 Days)
- RFMZ 76.6K
- SMTI 55.5K
- Earning Date
- RFMZ 01-01-0001
- SMTI 08-11-2025
- Dividend Yield
- RFMZ 7.43%
- SMTI N/A
- EPS Growth
- RFMZ N/A
- SMTI N/A
- EPS
- RFMZ 0.65
- SMTI N/A
- Revenue
- RFMZ N/A
- SMTI $91,569,883.00
- Revenue This Year
- RFMZ N/A
- SMTI $23.53
- Revenue Next Year
- RFMZ N/A
- SMTI $5.93
- P/E Ratio
- RFMZ $21.49
- SMTI N/A
- Revenue Growth
- RFMZ N/A
- SMTI 34.65
- 52 Week Low
- RFMZ $11.28
- SMTI $25.86
- 52 Week High
- RFMZ $14.57
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- RFMZ 46.96
- SMTI 48.14
- Support Level
- RFMZ $12.67
- SMTI $28.71
- Resistance Level
- RFMZ $12.84
- SMTI $30.94
- Average True Range (ATR)
- RFMZ 0.11
- SMTI 1.02
- MACD
- RFMZ 0.01
- SMTI 0.10
- Stochastic Oscillator
- RFMZ 51.28
- SMTI 39.81
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.